A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

NCT00207766 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: infliximab or placebo

Sponsor

Centocor, Inc.